Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseasesNEW YORK, Dec. 11, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback